Advertisement

Topics

Alnylam's Onpattro Carries Narrower hATTR Indication Without Cardiac Data

19:34 EDT 13 Aug 2018 | SCRIP

US FDA still appears to be open, if not optimistic, about path towards broader label for patisiran, the first-of-its-kind targeted...

      

Related Stories

 

Original Article: Alnylam's Onpattro Carries Narrower hATTR Indication Without Cardiac Data

NEXT ARTICLE

More From BioPortfolio on "Alnylam's Onpattro Carries Narrower hATTR Indication Without Cardiac Data"

Advertisement
Quick Search
Advertisement
Advertisement